Published: May 31, 2024

HOYA is shaping the future of vision care

As global demand for vision care grows, HOYA is leading the way with its innovative MiYOSMART to slow down childhood myopia progression.

Author: Hoya

Myopia and the vision health gap

According to the World Health Organization’s 2023 statistics, at least 2.2 billion people globally have a near or distance vision impairment, with uncorrected refractive errors being one of the main causes.(1) Myopia, also known as short-sightedness, is estimated to affect half of the world’s population by 2050.(2) The vision health gap is immense and still growing,(3) signifying the demand for better vision care.

kids playing

Annual myopia progression rate is most rapid for children under 10.(4) Greater rates of myopia progression usually lead to high myopia and lasting vision complications if not treated, such as macular degeneration, retinal detachment or even glaucoma which may lead to irreversible blindness.

There is a lack of awareness of myopia and its impact amongst patients and the parents of children living with the condition. People do not think there is something to be done to delay the onset of myopia and slow down its progression. This is false – myopia is not reversible, but it can be slowed down or even stopped.

Improving Vision Health in children with HOYA MiYOSMART

At HOYA, we are dedicated to improving vision health in children and raising awareness about medical eye condition, myopia.

HOYA Vision Care is leading the way in myopia management through MiYOSMART*, a spectacle lens based on revolutionary Defocus Incorporated Multiple Segments (D.I.M.S.) Technology. Diagnosing myopia in children early helps not only correct their vision but also provide myopia management solutions earlier to slow down the myopia progression and preserve their vision and eye health for the future.

graph
*MiYOSMART is not approved for myopia management in all countries, including the United States, and is not currently available for sale in all countries, including the United States.

Shaping the future of vision care

HOYA Vision Care is attending the Global Health Summit which will feature a series of panel discussions with industry leaders from across the world to confront global health issues. We call for the whole healthcare ecosystem to act now and work together to prioritize its treatment as a public health concern and support education of the condition – making people understand the impact myopia can have on children and the importance of seeking timely treatment.

Every child deserves to have better treatment for their vision health. HOYA is committed to continue fighting this problem through advances in technology and innovation to enable better treatment solutions, allowing children to lead fuller, and more inclusive lives.

(1) WHO. Blindness and vision impairment key facts. Accessed April 2024. Blindness and vision impairment (who.int)

(2) Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S, Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050, Ophthalmology, May 2016 Volume 123, Issue 5, Pages 1036-1042

(3) Nature. Stern J, et al. Accessed April 2024. 2030 In Sight: the future of global eye health | Eye (nature.com)

(4) Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S, Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050, Ophthalmology, May 2016 Volume 123, Issue 5, Pages 1036-1042

  • health
    Inspiring Action for a Healthier Tomorrow

    The Global Health documentary series explores pioneering developments within the healthcare sector.

    Read more

More from Global Health

    This advertiser content has been created and paid for by ACUMEN. Neither Reuters News nor Reuters Plus, the brand marketing studio of Reuters, were involved/had a role in the production of this content.